Polycystic Ovarian Syndrome Treatment Market to Incur Steady Growth $4,184 million by 2026 | CAGR 4.7%

The global polycystic ovarian syndrome treatment market size was valued at $2,902 million in 2018, and is projected to reach $4,184  million by 2026, growing at a CAGR of 4.7% from 2019 to 2026.

Polycystic ovarian syndrome or PCOS is a hormonal disorder that occurs in women during their childbearing age and is characterized by formation of cyst on ovaries. PCOS often leads to hirsutism, obesity, infertility, and diabetes, thus, needs effective management. Presently, there is no cure for PCOS, but different types of medications, such as insulin sensitizing agent, oral contraceptive, antiandrogens, and anti-obesity drugs are used to manage PCOS. 

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/6314

The polycystic ovarian syndrome treatment market is expected to experience significant growth during the forecast period owing to rise in demand for PCOS treatment medication across different regions and increase in popularity combination therapy majorly drives the market growth. Increase in prevalence of PCOS is expected to further boost the polycystic ovarian syndrome treatment market growth during the forecast period. In addition, significant unmet need for PCOS treatment, increase in R&D activities to develop PCOS therapeutics, and growing demand forof PCOS therapeutics in developing countries further creates opportunities for the PCOS treatment market. However, lack of approved drugs and adverse effects associated with off label drugs are anticipated to hamper the market growth. 

On the basis of drug class, the market is categorized into insulin sensitizing agent, oral contraceptive, antiandrogens, anti-obesity drugs, and others. Presently, the insulin sensitizing agent segment is the major revenue contributing segment and is estimated to show a significant market growth during the forecast period, owing to higher adoption of insulin sensitizing agents as first line treatment in the management of PCOS.

According to distribution channel, the polycystic ovarian syndrome treatment market is classified into hospital pharmacies, drug stores & retail pharmacies, and online providers. The online providers segment is anticipated to depict significant growth during the forecast period, attributed to the rise in preference for online purchasing of drugs over traditional methods, increase in awareness of online pharmacy, and rise in number of internet users.

Get a purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/6314

North America accounted for approximately one-half of the global polycystic ovarian syndrome treatment market share in 2018 and is expected to remain dominant throughout the forecast period. This was attributed to the rise in adoption of polycystic ovarian syndrome treatment medications, well developed healthcare infrastructure, large number of target population with higher health awareness, wide availability of advanced polycystic ovarian syndrome treatment therapeutics, and supportive reimbursement policies in the healthcare system. In addition, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to growing prevalence of PCOS, and increase in the adoption of polycystic ovarian syndrome treatment medication for the same. 

The Major key players Are:

• Allergan plc.

• AstraZeneca plc.

• Bayer AG

• Bristol-Myers Squibb Company

• Johnson and Johnson

• Mylan N.V.

• Novartis AG

• Pfizer Inc.

• SANOFI

• Teva Pharmaceutical Industries.

Key Findings of the Study:

1. Based on drug class, the insulin sensitizing agent segment held more than one half of share in the global market in 2018.

2. Based on end user, the online providers segment exhibits fastest growth and is expected to grow at a CAGR of 6.3% from 2019 to 2026. 

3. Based on end user, the drug stores & retail pharmacies segment held the largest market share in 2018 and is expected to remain dominant throughout the forecast period. 

4. Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.3% during the forecast period.

Similar Reports:

Nuclear Medicine Market

Asia-Pacific Medical Carts Market

Respiratory Care Devices Market

Intraoperative Neuromonitoring Market

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Market Pulse: https://blog.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at contact@wiredrelease.com.